186 related articles for article (PubMed ID: 33104848)
21. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Tang Z; Feng W; Yang Y; Wang Q
Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.
Gong JH; Zheng YB; Zhang MR; Wang YX; Yang SQ; Wang RH; Miao QF; Liu XJ; Zhen YS
Cancer Biol Ther; 2020 Apr; 21(4):332-343. PubMed ID: 31906826
[TBL] [Abstract][Full Text] [Related]
23. Exploiting antidiabetic activity of silver nanoparticles synthesized using Punica granatum leaves and anticancer potential against human liver cancer cells (HepG2).
Saratale RG; Shin HS; Kumar G; Benelli G; Kim DS; Saratale GD
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):211-222. PubMed ID: 28612655
[TBL] [Abstract][Full Text] [Related]
24. Hormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cells.
Jiao ZH; Li M; Feng YX; Shi JC; Zhang J; Shao B
PLoS One; 2014; 9(7):e102564. PubMed ID: 25033410
[TBL] [Abstract][Full Text] [Related]
25. The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.
Matsumoto K; Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2008 Oct; 20(4):863-72. PubMed ID: 18813828
[TBL] [Abstract][Full Text] [Related]
26. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
[TBL] [Abstract][Full Text] [Related]
27. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
29. Fabrication and Cytotoxicity of Gemcitabine-Functionalized Magnetite Nanoparticles.
Popescu RC; Andronescu E; Vasile BȘ; Truşcă R; Boldeiu A; Mogoantă L; Mogoșanu GD; Temelie M; Radu M; Grumezescu AM; Savu D
Molecules; 2017 Jun; 22(7):. PubMed ID: 28657606
[TBL] [Abstract][Full Text] [Related]
30. Bactericidal application and cytotoxic activity of biosynthesized silver nanoparticles with an extract of the red seaweed Pterocladiella capillacea on the HepG2 cell line.
El Kassas HY; Attia AA
Asian Pac J Cancer Prev; 2014; 15(3):1299-306. PubMed ID: 24606456
[TBL] [Abstract][Full Text] [Related]
31. Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.
Nair AB; Shah J; Al-Dhubiab BE; Patel SS; Morsy MA; Patel V; Chavda V; Jacob S; Sreeharsha N; Shinu P; Attimarad M; Venugopala KN
Molecules; 2019 Dec; 24(24):. PubMed ID: 31847085
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial.
Yang TS; Wang CH; Hsieh RK; Chen JS; Fung MC
Ann Oncol; 2002 Nov; 13(11):1771-8. PubMed ID: 12419750
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
Sun L; Zhou DS; Zhang P; Li QH; Liu P
Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
[TBL] [Abstract][Full Text] [Related]
34. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Jeyaraj M; Kim JH
Biomed Res Int; 2013; 2013():535796. PubMed ID: 23936814
[TBL] [Abstract][Full Text] [Related]
36. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
[TBL] [Abstract][Full Text] [Related]
37. 4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest.
Liu S; Zhao Y; Cui HF; Cao CY; Zhang YB
J BUON; 2016; 21(5):1195-1202. PubMed ID: 27837623
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
[TBL] [Abstract][Full Text] [Related]
39. Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma.
Hung CS; Lin SF; Liu HH; Kuo LJ; Li LT; Su HY; Liew PL; Lin FY; Wei PL; Liu DZ; Chang YJ
Ann Surg Oncol; 2012 Aug; 19(8):2744-52. PubMed ID: 22258814
[TBL] [Abstract][Full Text] [Related]
40. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
Yilmaz S; Ichedef C; Karatay KB; Teksöz S
Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
